N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-3-p-tolylpropanamide

ID: ALA1956436

PubChem CID: 16644244

Max Phase: Preclinical

Molecular Formula: C19H20N2OS

Molecular Weight: 324.45

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(CCC(=O)Nc2sc3c(c2C#N)CCCC3)cc1

Standard InChI:  InChI=1S/C19H20N2OS/c1-13-6-8-14(9-7-13)10-11-18(22)21-19-16(12-20)15-4-2-3-5-17(15)23-19/h6-9H,2-5,10-11H2,1H3,(H,21,22)

Standard InChI Key:  JLIAFBWUJUWJGZ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 23 25  0  0  0  0  0  0  0  0999 V2000
   -4.0228   -8.6217    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3618   -8.1297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6254   -7.3488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6951   -8.1450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4532   -7.3582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0105   -6.7584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8129   -6.9399    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0575   -7.7267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4945   -8.3322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1473   -6.6717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6695   -5.9980    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6434   -8.5371    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9315   -8.1186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2130   -8.5261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9378   -7.2928    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2067   -9.3518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4884   -9.7592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4844  -10.5828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2330  -10.9901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9461  -10.5717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9371   -9.7415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2189   -9.3380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6650  -10.9781    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  3 10  1  0
  1  2  1  0
  2 12  1  0
  2  3  2  0
 12 13  1  0
  3  5  1  0
 13 14  1  0
  4  5  2  0
 13 15  2  0
  4  9  1  0
 14 16  1  0
  5  6  1  0
 16 17  1  0
  6  7  1  0
 17 18  2  0
  7  8  1  0
 18 19  1  0
  8  9  1  0
 19 20  2  0
  4  1  1  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
 10 11  3  0
 20 23  1  0
M  END

Associated Targets(Human)

NCI-H727 (447 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H1299 (3248 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Calu-6 (398 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Vipr1 Vasoactive intestinal polypeptide receptor 1 (86 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 324.45Molecular Weight (Monoisotopic): 324.1296AlogP: 4.38#Rotatable Bonds: 4
Polar Surface Area: 52.89Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 10.50CX Basic pKa: CX LogP: 5.39CX LogD: 5.39
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.91Np Likeness Score: -2.02

References

1. Harikrishnan LS, Srivastava N, Kayser LE, Nirschl DS, Kumaragurubaran K, Roy A, Gupta A, Karmakar S, Karatt T, Mathur A, Burford NT, Chen J, Kong Y, Cvijic M, Cooper CB, Poss MA, Trainor GL, Wong TW..  (2012)  Identification and optimization of small molecule antagonists of vasoactive intestinal peptide receptor-1 (VIPR1).,  22  (6): [PMID:22365758] [10.1016/j.bmcl.2012.01.082]

Source